TILT Holdings (TLLTF) Consolidated Net Income (2021 - 2025)
TILT Holdings (TLLTF) reported Consolidated Net Income of -$2.9 million for Q2 2025, up 84.99% on a YoY basis from -$1.6 million in Q2 2024, and up 78.01% quarter-over-quarter from -$13.2 million in Q1 2025.
TILT Holdings (TLLTF) Consolidated Net Income (2021 - 2025) Analysis & Trends
TILT Holdings has reported Consolidated Net Income for 5 years, with the latest figure at -$2.9 million in Q2 2025.
- For the quarter ending Q2 2025, Consolidated Net Income rose 84.99% year-over-year to -$2.9 million; the trailing twelve-month figure through Jun 2025 stood at -$65.5 million (down 2.87% YoY), and the FY2024 full-year result was -$94.9 million, down 39.99% from the prior year.
- Consolidated Net Income for Q2 2025 stood at -$2.9 million, up from -$13.2 million in the prior quarter.
- The five-year high for Consolidated Net Income was $1.0 million in Q2 2021, with the low at -$71.6 million in Q4 2022.
- Historically, Consolidated Net Income has averaged -$16.8 million across 5 years, with a median of -$12.6 million in 2024.
- Annual changes were most pronounced in 2022 — Consolidated Net Income sank 1629.34% — and 2025, when it soared 84.99%.
- TILT Holdings' Consolidated Net Income stood at -$20.1 million in 2021, then tumbled by 255.85% to -$71.6 million in 2022, then jumped by 63.76% to -$26.0 million in 2023, then plunged by 41.37% to -$36.7 million in 2024, then jumped by 92.07% to -$2.9 million in 2025.
- The last three Consolidated Net Income figures came in at -$2.9 million (Q2 2025), -$13.2 million (Q1 2025), and -$36.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn | -2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2.91 Mn |
| Mar 31, 2025 | -13.24 Mn |
| Dec 31, 2024 | -36.70 Mn |
| Sep 30, 2024 | -12.65 Mn |
| Jun 30, 2024 | -19.40 Mn |
| Mar 31, 2024 | -9.65 Mn |
| Dec 31, 2023 | -25.96 Mn |
| Sep 30, 2023 | -8.66 Mn |
| Jun 30, 2023 | -28.34 Mn |
| Mar 31, 2023 | -4.87 Mn |
| Dec 31, 2022 | -71.63 Mn |
| Sep 30, 2022 | -15.69 Mn |
| Jun 30, 2022 | -7.05 Mn |
| Mar 31, 2022 | -11.63 Mn |
| Dec 31, 2021 | -20.13 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 1.03 Mn |